By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sanofi Pasteur 

174, av. de France

Paris    75013  France
Phone: 33-1-53-77-4076 Fax: 33-1-53-77-4174



Company News
Sanofi Pasteur (SASY.PA) Proposes Expansion that Will Create 100 New Jobs in Pennsylvania 11/16/2015 6:56:08 AM
Infectious Disease Research Institute (IDRI) And Sanofi Pasteur (SASY.PA) Team With Philanthropy To Develop New Model For Vaccine Development 10/15/2015 9:52:49 AM
Dyadic International, Inc. Receives C1 Derived Vaccine Test Results From Sanofi Pasteur (SASY.PA) And Provides Further Details On New EU-Funded ZAPI Biopharmaceutical Program 10/7/2015 11:45:21 AM
Sanofi Pasteur (SASY.PA) Release: New Analysis Reports Lower Rates Of Serious Cardio-Respiratory Events Among Study Participants Administered Higher-Dose Influenza Vaccine 8/3/2015 6:33:17 AM
Sanofi Pasteur (SASY.PA) Ships First 2015-2016 Seasonal Influenza Vaccine Doses In United States 7/14/2015 6:49:37 AM
VBI Vaccines Announces Research Collaboration With Sanofi Pasteur (SASY.PA) To Enhance Vaccine Stability 4/7/2015 7:12:57 AM
Sanofi Pasteur (SASY.PA) Announces FDA Approval Of Quadracel Dtap-IPV Vaccine For Children 4 Through 6 Years Of Age 3/25/2015 12:56:14 PM
EXCLUSIVE: Sanofi Pasteur (SASY.PA) US CMO Says U.S. Regulators Most Interested in Four-Strain Flu Vax 12/18/2014 12:41:28 PM
Sanofi Pasteur (SASY.PA) Announces FDA Approval Of Fluzone Intradermal Quadrivalent (Influenza Vaccine) For Adults 12/12/2014 7:57:24 AM
Sanofi Pasteur (SASY.PA)'s Investigational Dengue Vaccine Hits Main Goal Showing Efficacy In Phase 3 Trial 11/4/2014 6:15:14 AM